Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

The 95 Billion Update: Access the REAL Space
April 9, 2026 13:57 CEST
The latest update of Enamine’s REAL Space brings a new expansion, now featuring over 94.5 billion accessible, drug-like products, approaching the 100 billion mark. Built from 173 curated reaction protocols and 202,620 in-stock reagents and building blocks based on Enamine’s in-house knowledge, this version further enhances the world’s largest commercially...
Read on
category
Challenge
Two Projects Win Scientific Challenge Spring 2025!
April 8, 2026 13:18 CEST
Deciding is not always easy. And sometimes it is especially hard. But since “hard” is not really our thing (something our easy-to-use software reflects as well), we decided this time to simply rationalize the difficulty away: instead of crowning just one project, we are celebrating two winners of the BioSolveIT...
Read on
SeeSAR 15 Apollo is here! - Download Now!
March 31, 2026 09:00 CEST
SeeSAR 15 ‘Apollo’ This marks the 50th Release of SeeSAR since inception. We are excited to introduce SeeSAR 15.0: a major update delivering advanced analysis and modeling capabilities. This release focuses on providing researchers with deeper insights and superior decision support through innovative new modes and workflow optimizations. Key innovations...
Read on